An epigenetics drug currently being used for the treatment of blood cancers and rare sarcomas can stop the growth of bladder cancer by activating the immune system, reports a new study in mice. The drug is now being tested in a national clinical trial for patients with late-stage bladder cancer.
from Healthy Aging News -- ScienceDaily https://ift.tt/0uUvJxP
No comments:
Post a Comment